Evaluation of the GlucoTrack, Non-Invasive Glucose Monitoring Device
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00433758|
Recruitment Status : Unknown
Verified September 2007 by Integrity Applications Ltd..
Recruitment status was: Active, not recruiting
First Posted : February 12, 2007
Last Update Posted : March 18, 2008
|Condition or disease||Intervention/treatment||Phase|
|Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus Gestational Diabetes||Device: GlucoTrack||Not Applicable|
Diabetes is a leading cause of death in the Western World with medical costs increasing annually. There is no cure for diabetes, and blood glucose monitoring is a key component in diabetes treatment and management. Consistently high blood sugar levels can, over time, lead to complications such as blindness, kidney disease, heart disease, and nerve damage.In addition, low blood sugars may lead to immediate dangers. Self-monitoring of blood glucose levels is essential to the self-management of diabetes and has become widespread over the past decade. Blood glucose determinations are currently done by invasive methods (finger tip pricking), followed by measuring the blood drop characteristics. Currently, there is no commercially available reliable non-invasive glucose measurement device that being marketed.
The GlucoTrack, non-invasive device for determining glucose levels based on the simultaneous measurement of three independent orthogonal parameters.
The rationale for development of the device is to improve the patient's quality of life by providing a device that is easily used and provides a painless measurement method, thereby leading to higher compliance, and to better managed diabetes
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||142 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Evaluation of the Performance and Use of the GlucoTrack(TM), Non-Invasive Glucose Monitoring Device|
|Study Start Date :||December 2006|
|Estimated Study Completion Date :||December 2008|
- Device: GlucoTrack
- Clarke Error Grid [ Time Frame: Clarke Error Grid ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00433758
|Soroka University Medical Center|
|Beer-Sheva, Israel, 84141|
|Principal Investigator:||Ilana Harman-Boehm, MD||Soroka University Medical Center|